Serve You Rx

Pharmacy benefit manager and pharmacy

Based in WI

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $20K in lobbying spend across 3 quarterly filings, Serve You Rx is an active lobbying client. Their lobbying covers 1 issue area.

$20K
Total Spend
1
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$20K

Issues Lobbied

Pharmacy

Lobbying Firms

Michael Best Strategies LLC

Lobbyists

Sarah Helton

Government Agencies Targeted

These are the government entities that Serve You Rx disclosed contacting in their lobbying filings.

Labor, Dept of (DOL)SENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy

issues relating to the implementation of CARES Act

issues relating to the implementation of the CARES Act

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Independent Pharmacy Cooperative
$1.5M total spend
Navitus Health Solutions
$296K total spend
Women's International Pharmacy
$169K total spend
Children's Hospital and Health System, INC.
$3.5M total spend
University of Wisconsin-madison
$3.0M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.